Montisera Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Montisera Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11281
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Montisera Ltd (Montisera) focuses on discovering, developing and commercialising bioactive compounds and molecules for pharmaceutical and food industries. Its pipeline portfolio includes Montisera D15 1 for alcoholism; Montisera D 4 for treating lower urinary tract symptoms, Montisera D15 2 for the treatment of parkinson’s disease; Montisera D15 3 for the prevention of alzheimer’s disease; and Montisera D2 9 for bark extract. Montisera’s research aims on developing novel products for various uses. The company seeks for partnerships and collaborations with various contract research organizations (CRO), science companies, laboratories, and universities for the development of its bioactive products. Montisera is headquartered in Raisio, Finland.

Montisera Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Montisera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Montisera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Montisera Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Montisera Acquires Extraction Technology Patents from UPM-Kymmene 10
Venture Financing 11
Montisera Raises USD0.32 Million in Seed A Round 11
Montisera to Raise USD0.74 Million in Seed B Round 12
Montisera Ltd – Key Competitors 13
Montisera Ltd – Key Employees 14
Montisera Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Montisera Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Montisera Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Montisera Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Montisera Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Montisera Acquires Extraction Technology Patents from UPM-Kymmene 10
Montisera Raises USD0.32 Million in Seed A Round 11
Montisera to Raise USD0.74 Million in Seed B Round 12
Montisera Ltd, Key Competitors 13
Montisera Ltd, Key Employees 14

List of Figures
Montisera Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Montisera Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Montisera Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Montisera Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KDDI Corporation:企業の戦略・SWOT・財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nexstim Plc (NXTMH):企業の財務・戦略的SWOT分析
    Nexstim Plc (NXTMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • St. Jude Children’s Research Hospital Inc-製薬・医療分野:企業M&A・提携分析
    Summary St. Jude Children’s Research Hospital Inc (St. Jude) is a healthcare service provider that offers research and clinical care services for children with catastrophic diseases. The hospital provides treatment programs such as brain tumors, leukemia, infectious diseases, immunodeficiency diseas …
  • Sanmina Corporation:企業の戦略・SWOT・財務情報
    Sanmina Corporation - Strategy, SWOT and Corporate Finance Report Summary Sanmina Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Oman Oil Co SAOC:石油・ガス:M&Aディール及び事業提携情報
    Summary Oman Oil Company SAOC (Oman Oil Company) is an oil and gas service provider that offers investment facilities for the growth and development of energy sector. The association invests and develops the areas of production, exploration, and related services, energy infrastructure and shipping, …
  • Cornerstone Capital Resources Inc (CGP):企業の財務・戦略的SWOT分析
    Summary Cornerstone Capital Resources Inc (Cornerstone) operates as a mining and mineral exploration and development company that offers mineral resources. The company offers acquisition, exploration, management, operations, production, mining, and development of rare earth elements, nickel, uranium …
  • Georgia-Pacific LLC:企業の戦略・SWOT・財務情報
    Georgia-Pacific LLC - Strategy, SWOT and Corporate Finance Report Summary Georgia-Pacific LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Genomic Health Inc (GHDX)-医療機器分野:企業M&A・提携分析
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Amoy Diagnostics Co Ltd (300685):医療機器:M&Aディール及び事業提携情報
    Summary Amoy Diagnostics Co Ltd (AmoyDx) is a developer of molecular diagnostics for oncology precision medicine. The company provides gene mutation products such as mutation detection kit and gene fusions detection kit. It offers nucleic acid extraction products including DNA and RNA extraction kit …
  • Koch Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Koch Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Koch Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Protalex Inc (PRTX):企業の財務・戦略的SWOT分析
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • Medidata Solutions Inc (MDSO):企業の財務・戦略的SWOT分析
    Medidata Solutions Inc (MDSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sinopharm Group Co Ltd (1099):製薬・医療:M&Aディール及び事業提携情報
    Summary Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp is a distributor of pharmaceutical and healthcare products. The group provides distribution, logistics and other value-added services to foreign and domestic manufacturers and suppliers of pharmaceut …
  • Patterson-UTI Energy, Inc. (PTEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Patterson-UTI Energy Inc (Patterson) is an oilfield service provider. It offers onshore contract drilling and pressure pumping services to oil and gas exploration and production companies. The company offers pressure pumping services such as well stimulation and cementing for completion of n …
  • Kathmandu Holdings Limited:企業の戦略・SWOT・財務情報
    Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ProThera Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ProThera Biologics Inc (ProThera), formerly ProThera Biologics LLC is a biotherapeutics company that develops novel products based on Inter-alpha Inhibitor Proteins. The company offers development of commercial potential of IAIP for treating acute, life-threatening inflammatory diseases. Pro …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • EnCana Corporation:企業の戦略・SWOT・財務情報
    EnCana Corporation - Strategy, SWOT and Corporate Finance Report Summary EnCana Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • United Cooperative Services, Inc.:企業の戦略的SWOT分析
    United Cooperative Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Medicontur Medical Engineering Ltd:製品パイプライン分析
    Summary Medicontur Medical Engineering Ltd (Medicontur) is a developer and manufacturer of intraocular lenses. The company offers hydrophilic and hydrophobic model lenses including monofocal aspheric, toric, and standard monofocal aspheric lenses; preloaded capsular tension rings; PMMA implants; inj …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆